SakamotoC, SoenS. Efficacy and safety of the selective cyclooxygenase-2 inhibitor celecoxib in the treatment of rheumatoid arthritis and osteoarthritis in Japan. Digestion2011; 83:108–23.
2.
NaranjoCA, BustoU, SellersEM. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981; 30:239–45.
3.
GriecoA, MieleL, GiorgiA, CivelloIM, GasbarriniG. Acute cholestatic hepatitis associated with celecoxib. Ann Pharmacother2002; 36:1887–9. DOI 10.1345/aph.1C110
4.
EsteveJB, Launay-VacherV, BrocheriouI, GrimaldiA, IzzedineH. COX-2 inhibitors and acute interstitial nephritis: case report and review of the literature. Clin Nephrol2005; 63:385–9.
